Skip to main content

Table 1 Effect of 10-day treatment on various metabolic parameters

From: Inhibition of 11βHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy mice

 

Vehicle

3 mg/kg

10 mg/kg

30 mg/kg

Rosiglitazone

Food Intake (g)

47.8 ± 2.2

48.6 ± 2.3

51.1 ± 1.9

42.9 ± 1.3

50.6 ± 1.2

Body Weight (g)

39.9 ± 0.7

42.9 ± 1.2

41.2 ± 1.0

43.5 ± 1.3

45.0 ± 1.0**

Body Weight as percent of initial (%)

96.4 ± 1.0

98.0 ± 0.7

98.1 ± 0.5

100.4 ± 0.1

107.3 ± 1.2**

Initial body weight (g)

41.4 ± 0.8

43.8 ± 1.2

41.9 ± 0.8

43.3 ± 1.3

41.9 ± 0.68

Fat Pad weight (g)

1.60 ± 0.07

1.72 ± 0.05

1.55 ± 0.04

1.50 ± 0.07

1.68 ± 0.07

Fat pad/body weight ×100

4.02 ± 0.18

4.03 ± 0.19

3.77 ± 0.14

3.54 ± 0.23

3.74 ± 0.16

Leptin (ng/ml)

57.2 ± 0.7

68.6 ± 4.5

59.4 ± 2.3

73.6 ± 3.1*

83.6 ± 2.9***

Insulin (ng/ml)

20.8 ± 5.2

23.6 ± 4.0

13.6 ± 4.6

17.7 ± 8.4

11.8 ± 2.5

Triglycerides (ng/ml)

1.90 ± 0.18

2.29 ± 0.13

2.6 ± 0.46

3.03 ± 0.30

2.3 ± 0.29

Liver triglycerides (mg/g liver)

14.7 ± 1.0

20.4 ± 3.0

15.2 ± 1.0

18.5 ± 1.4

20.9 ± 2.0

Total cholesterol (mM)

4.0 ± 0.2

3.9 ± 0.1

4.0 ± 0.1

4.1 ± 0.2

5.1 ± 0.3**

HDL cholesterol (mM)

3.1 ± 0.2

3.0 ± 0.1

3.1 ± 0.1

3.2 ± 1.3

4.1 ± 0.2**

Liver cholesterol (mg/g liver)

4.0 ± 0.2

3.8 ± 0.2

4.3 ± 0.2

3.6 ± 0.1

3.2 ± 0.1*

  1. Data are mean ± SEM, n = 8 per group. *p < 0.05, **p < 0.01 and ***p < 0.001 significantly different from vehicle